Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
 |
Results for 'Valsartan: Pipeline™ Selector' |
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
|
Valsartan Pipeline Developer |
Ongoing | £3795 | 100 % |
|
Valsartan: Extended Country Coverage Pipeline Selector |
Ongoing | £610 | 96 % |
|
Valsartan: Core Country Coverage Pipeline Selector |
Ongoing | £260 | 96 % |
|
Novartis Pipeline ,Products ,Performance ,Potential |
November 2009 | £595 | 35 % |
|
Cardiovascular Pharmaceutical Market Trends, 2007 to 2010 Key market forecasts and growth opportunities |
August 2007 | £895 | 27.65 % |
|
Report on Antihypertensive Drug Market |
May 2009 | £350 | 23.8 % |
|
Pharmaceutical Market Trends, 2008 - 2012 Key market forecasts and growth opportunities (3rd Edition) |
November 2008 | £1350 | 17.15 % |
|
Pharmaceutical Product Approval Trends, 2007 Key Market Benchmarks And Strategic Insights |
December 2007 | £995 | 17.15 % |
|
China Hypertension Drug Market Report The Chinese Hospital Cancer Drug Utilization |
February 2009 | £5090 | 16.8 % |
|
The Cardiovascular Disorders Market Outlook to 2012 |
February 2008 | £1995 | 16.1 % |
|
Hypertension - Treatments and Prescribing Practices A Global Survey 2009 |
October 2009 | £4165 | 16.1 % |
|
Commercial Insight: Antihypertensives New challenges for a maturing market |
September 2006 | £8000 | 15.75 % |
|
Pipeline/Commercial Insight: Antihypertensives New class opportunity offset by key patent expiries |
July 2007 | £7600 | 13.65 % |
|
Innovations in Cardiovascular Disease Management Latest surgical procedures, drugs and medical devices |
September 2007 | £1495 | 12.95 % |
|
Teva Pharmaceutical Industries Generics Company Intelligence Report |
June 2008 | £195 | 10.85 % |
|
Handbook of Pharmaceutical Manufacturing Formulations - Vol 2 of 6 Uncompressed Solid Products |
April 2007 | £195 | 10.15 % |
|
Chinese Markets for Hypertension Drugs |
April 2009 | £2755 | 9.1 % |
|
Teva Generics Company Intelligence Report Company Intelligence Report |
March 2009 | £195 | 9.1 % |
|
Alzheimer's Disease New Drugs, Markets and Companies |
October 2009 | £1910 | 5.95 % |
|
Commercial Insight: Cardiovascular market overview Raft of patent expires threaten blockbusters |
October 2007 | £7600 | 5.6 % |
|
Cardiovascular Generic Drugs Prospects and Opportunities to 2012 |
December 2007 | £995 | 5.6 % |
|
Handbook of Pharmaceutical Manufacturing Formulations - Vol 1 of 6 Compressed Solid Products |
April 2007 | £195 | 4.9 % |
|
Alzheimer's disease New Drugs, Markets and Companies |
October 2009 | £1910 | 2.45 % |
|
Alzheimer's disease New drugs, markets and companies |
December 2008 | £1910 | 2.45 % |
|
Alzheimer Disease New Drugs, Markets and Companies |
May 2009 | £1780 | 2.45 % |
|
World Generic Market Report 2009 |
January 2009 | £595 | 2.45 % |
